| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
phenotype | 0.400 | None | 1.000 | 0 | 0 | 2006 | 2006 | ||||||||
|
serpin family A member 6 | 0.606 | 0.731 | 8.3E-07 |
|
phenotype | 0.190 | None | 1.000 | 0 | 0 | 2001 | 2016 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
phenotype | 0.160 | None | 1.000 | 0 | 0 | 2010 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
phenotype | 0.140 | None | 1.000 | 0 | 0 | 2013 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
phenotype | 0.130 | None | 1.000 | 0 | 0 | 2004 | 2011 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2010 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2012 | 2015 | ||||||||
|
solute carrier family 26 member 4 | 0.507 | 0.885 | 9.0E-22 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2018 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2001 | 2017 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 0 | 2017 | 2018 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
thyroid stimulating hormone receptor | 0.486 | 0.808 | 3.0E-15 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2012 | 2012 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2019 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2014 | 2014 | ||||||||
|
ribosomal protein S27 | 0.578 | 0.769 | 0.76 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2018 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2009 | 2009 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.110 | None | < 0.001 | 0 | 0 | 2012 | 2012 | ||||||||
|
proteinase 3 | 0.503 | 0.808 | 3.8E-05 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2020 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.110 | None | < 0.001 | 0 | 0 | 2018 | 2018 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2017 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 0 | 2019 | 2019 |